Zaleplon
Zaleplon
Brand names:Sonata
A short-acting Z-class sedative-hypnotic (GABA-A alpha-1 selective) used as a 4-hour sleep aid during controlled rest cycles in sustained operations. Zaleplon's 1-hour half-life is the operational advantage: useful for brief protected rest with minimal residual sedation if operations resume. Schedule IV with FDA boxed warning for complex sleep behaviors. Must have at least 4 hours of protected rest available before dosing.
Pharmacology and Actions
Zaleplon selectively binds to the GABA-A receptor alpha-1 subunit (the same subunit responsible for the sedative effects of benzodiazepines) but with much greater subunit selectivity. This selectivity is why zaleplon has stronger sleep-induction effect with less anxiolytic, muscle-relaxant, and anticonvulsant activity than benzodiazepines. Very short half-life (1 hour) limits residual sedation.
Indications
- Short-term treatment of insomnia, particularly difficulty falling asleep
- Operational use as 4-hour sleep aid for tactical personnel before short rest periods (crew rest or controlled rest cycles)
Absolute Contraindications
- Known hypersensitivity to zaleplon or other sedative-hypnotics
- History of complex sleep behaviors (sleep-driving, sleep-walking, sleep-eating)
- Severe hepatic impairment
Precautions and Side Effects
Common: headache, drowsiness, dizziness, nausea. FDA boxed warning: complex sleep behaviors (sleep-driving, sleep-walking, sleep-eating), sometimes with no memory. Memory impairment if dose taken without adequate sleep opportunity. Dependence and withdrawal with chronic use. Paradoxical reactions (agitation, hallucinations) uncommon but reported. Drug interactions: additive CNS depression with alcohol, opioids, benzodiazepines, and other sedatives; CYP3A4 inhibitors (ketoconazole, erythromycin, ritonavir) may modestly increase levels (smaller effect than for zolpidem); cimetidine increases zaleplon levels (avoid combination if possible). Half-life 1 hour - the operational advantage. Pregnancy Category C. Small amounts in breast milk; safer alternatives preferred. Elderly: 5 mg starting dose; increased falls and confusion risk. Hepatic impairment: reduce dose. Standard renal dosing. Operator must have protected rest time available and cannot return to duty until clear.
Adult Dosing
Pediatric Dosing
Not recommended in children.
Pharmacokinetics
Peak Effect: 1 hour.
Duration: 4 hours.
Storage and Handling
Schedule IV controlled substance - secured storage, chain of custody documentation, administration log. Room temperature, protect from light and moisture.
Reconstitution:
Oral formulation only. Capsules.
TCCC and TECC Role
Zaleplon is not in the TCCC formulary. It appears in tactical EMS supplemental formularies and military operational medicine as the preferred short-acting sleep aid for sustained operations and controlled rest cycles. The 4-hour duration matches the typical 4 to 6 hour rest window in many sustained operations. The 1-hour half-life means minimal residual sedation if awakened or if operations resume at hour 4. Classified as non-mission-capable during the active drug window - the operator must have protected rest time and cannot return to duty until clear.
Sustained operations demand sleep management. Zaleplon's operational profile is purpose-built for the 4-hour controlled rest cycle: rapid onset, sufficient sleep duration, minimal hangover. The military and special operations communities have studied Z-drugs extensively for this use case. Standard protocols require that zaleplon be given only when at least 4 hours of protected rest is available and a contingency operator is on duty during the medication window. Never use zaleplon recreationally or to manage routine sleep difficulty in operational personnel - the operational use is strictly for crew rest in sustained operations.
Taking zaleplon with less than 4 hours of available rest. The operator wakes still impaired, attempts to function, and has impaired judgment and motor control with no awareness. The other mistake is combining with alcohol or other CNS depressants - the operational protocol is single-agent use in a protected rest period, and any alcohol within 6 to 8 hours of dosing is disqualifying.
This drug profile is provided as educational reference material for trained medical providers. It is not medical advice, not a substitute for formal training, and not a substitute for current published guidelines or medical direction.
Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances are subject to additional handling, accountability, and documentation requirements per DEA and state law. Always verify dosing, indications, contraindications, and route of administration against current published guidelines and your local protocols before administration.
If this content is being viewed during a medical emergency, call 911 immediately and follow the direction of your local emergency dispatch and medical control. Do not use this reference as a substitute for emergency medical services.
Drug information evolves. Last reviewed dates and source citations are provided for each entry. Confirm currency against the cited source before clinical use.
Penn Tactical Solutions publishes this reference for educational purposes. PTS does not provide medical direction and does not assume responsibility for clinical decisions made in the field. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Educational reference for trained medical providers. Not medical advice. Not a substitute for formal training, current published guidelines, or medical direction. Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances require additional storage, accountability, and documentation per DEA and state law.
In a medical emergency, call 911. This reference is not a substitute for emergency medical services.
Verify dosing, indications, and contraindications against current published guidelines and your local protocols before administration. Confirm content currency against the source citation. Penn Tactical Solutions does not provide medical direction. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Zaleplon
Schedule IV| IV/IO | None (None) |
| IM | None (None) |
| IN | None (None) |
| PO | 5 to 10 mg PO at bedtime. Maximum 20 mg. Onset is rapid (under 30 minutes) so should be taken only when ready to sleep with at least 4 hours available before next duty period. Reduce to 5 mg in elderly, low body weight, or hepatic impairment. (15 to 30 minutes) |